Paul J Lynch MD PLLC

Paul J Lynch MD PLLC, a Scottsdale, Arizona-based for-profit partnership, provides expert witness and medical consultation services to the Department of Justice and its components as a prime contractor, competing entirely in the open market without set-aside designation across 46 awards totaling $1.1 million in combined potential value. The vendor operates exclusively as a prime (100% of awards) and serves only four distinct federal customer agencies, all within the Department of Justice family.

The Department of Justice Drug Enforcement Administration dominates the customer base, accounting for 40 awards (87% of total awards) with $848 thousand in combined potential value. The U.S. Attorney's Offices follow with 4 awards valued at $111 thousand, the Civil Division with 1 award at $104 thousand, and the Criminal Division with 1 award at $44 thousand. This concentration reflects a narrowly focused business model built on controlled-substance enforcement and medical-legal consulting.

Paul J Lynch MD PLLC's service portfolio centers on medical record review, controlled substance prescription monitoring program (CSPMP) data analysis, expert report writing, and expert witness testimony in administrative hearings and legal proceedings. Recent representative work includes a $73,500 firm fixed-price expert witness consulting order awarded by DEA on July 15, 2026, a $47,764.17 time-and-materials expert witness order from U.S. Attorney's Offices on November 14, 2024, and a $91,200 labor-hours contract with DEA on November 20, 2023, for medical file and CSPMP data review, report composition, and pre-hearing preparation. The vendor's pricing varies by engagement—labor-hours, firm fixed-price, and time-and-materials structures appear across the portfolio. Most contracts carry one-year periods of performance and ceilings ranging from approximately $1,250 to $91,200.

Activity has grown unevenly over the past five years: five awards in 2022, five in 2023, twelve in 2024, eight in 2025, and ten in 2026 year to date. The vendor faces recompete exposure of $285 thousand across ten awards completing within the next twenty-four months. The portfolio shows 94% of combined potential value obligated, indicating strong cash conversion and consistent utilization of awarded ceiling values. All awards were procured without SBA set-aside designation, and the vendor operates across multiple geographic performance sites including Scottsdale and Tucson, Arizona; Salt Lake City, Utah; Seattle, Washington; Portland, Oregon; Los Angeles, California; and Washington, DC.

The vendor's category concentration aligns with its core function: the PSC coding reflects 36 awards tagged as "Support—Professional: Expert Witness," 9 as "Technical Medical Support," and 1 as "Support—Professional: Engineering/Technical." NAICS coding shows General Medical and Surgical Hospitals as the leading category (27 awards), followed by All Other Professional, Scientific, and Technical Services (11 awards) and Offices of Physicians (4 awards), a pattern reflecting the classification system's fit for medical consulting rather than the vendor's operational scope.